Skip to content

Clinical trials

Enrolling by invitation Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Enrolling by invitation Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20201
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica1
National Cancer Institute (NCI)1
National Institutes of Health Clinical Center (CC)1
Rondo Therapeutics1
Rutgers, The State University of New Jersey1
University of Valencia1
Wren Laboratories LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma7
Prostatic Neoplasms5
Neoplasms2
Urinary Bladder Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Diabetes Mellitus1
Endometrial Neoplasms1
Erectile Dysfunction1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.